Effects of anti-viral drug (vidarabine) on atrial fibrillation and ventricular arrhythmia
Not Applicable
- Conditions
- Arrhythmia
- Registration Number
- JPRN-UMIN000006026
- Lead Sponsor
- Yokohama City University,Cardiovascular Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 10
Inclusion Criteria
Not provided
Exclusion Criteria
Central nervous disease Severe liver dysfunction Severe renal dysfunction
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1) Time to terminate the atrial fibrillation 2) The decrease number of ventricular arrhythmia
- Secondary Outcome Measures
Name Time Method